Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
{{output}}
Introduction: The transcription factor MYC is overexpressed in 30% of small cell lung cancer (SCLC) tumors and is known to modulate the balance between two major pathways of metabolism: glycolysis and mitochondrial respiration. T... ...
